{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T07:53:17Z","timestamp":1775202797601,"version":"3.50.1"},"reference-count":26,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003441","name":"Universitair Ziekenhuis Gent","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003441","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","hpbonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["HPB"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.hpb.2025.10.003","type":"journal-article","created":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:45:06Z","timestamp":1760139906000},"page":"35-42","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Success rate of salvage neoadjuvant chemotherapy for unexpectedly identified locally advanced pancreatic ductal adenocarcinoma during surgical exploration"],"prefix":"10.1016","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-0802-8446","authenticated-orcid":false,"given":"Filip","family":"Gryspeerdt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5821-5512","authenticated-orcid":false,"given":"Lu\u00eds Filipe Abreu","family":"de Carvalho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niki","family":"Rashidian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzane","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0736-2034","authenticated-orcid":false,"given":"Anne","family":"Hoorens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Geboes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3575-5345","authenticated-orcid":false,"given":"Frederik","family":"Berrevoet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.hpb.2025.10.003_bib1","doi-asserted-by":"crossref","first-page":"10","DOI":"10.14740\/wjon1166","article-title":"Epidemiology of pancreatic cancer: global trends, etiology and risk factors","volume":"10","author":"Rawla","year":"2019","journal-title":"World J Oncol"},{"key":"10.1016\/j.hpb.2025.10.003_bib2","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1002\/bjs.10602","article-title":"Nationwide outcomes in patients undergoing surgical exploration without resection for pancreatic cancer","volume":"104","author":"van der Geest","year":"2017","journal-title":"Br J Surg"},{"key":"10.1016\/j.hpb.2025.10.003_bib3","doi-asserted-by":"crossref","DOI":"10.1186\/s12893-023-02200-6","article-title":"Predictive factors for survival in borderline resectable and locally advanced pancreatic cancer: are these really two different entities?","volume":"23","author":"de Carvalho","year":"2023","journal-title":"BMC Surg"},{"key":"10.1016\/j.hpb.2025.10.003_bib4","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1093\/bjs\/znab133","article-title":"Technical advances in surgery for pancreatic cancer","volume":"108","author":"Schneider","year":"2021","journal-title":"Br J Surg"},{"key":"10.1016\/j.hpb.2025.10.003_bib5","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1097\/SLA.0000000000001731","article-title":"Pancreatic cancer surgery","volume":"265","author":"Strobel","year":"2017","journal-title":"Ann Surg"},{"key":"10.1016\/j.hpb.2025.10.003_bib6","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1093\/bjs\/znaa146","article-title":"Effect of centralization and regionalization of pancreatic surgery on resection rates and survival","volume":"108","author":"Latenstein","year":"2021","journal-title":"Br J Surg"},{"key":"10.1016\/j.hpb.2025.10.003_bib7","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jamcollsurg.2012.03.024","article-title":"Multimodality therapy offers a chance for cure in patients with pancreatic adenocarcinoma deemed unresectable at first operative exploration","volume":"215","author":"Truty","year":"2012","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.hpb.2025.10.003_bib8","article-title":"Pancreatic adenocarcinoma, Version 1.2022, NCCN Clinical Practice Guidelines in Oncology","author":"Tempero","year":"2022","journal-title":"Natl Compr Cancer Netw"},{"key":"10.1016\/j.hpb.2025.10.003_bib9","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New Response Evaluation Criteria in Solid Tumours: revised RECIST Guideline (Version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.hpb.2025.10.003_bib10","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","article-title":"Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and Results of a Survey","volume":"240","author":"Dindo","year":"2004","journal-title":"Ann Surg"},{"key":"10.1016\/j.hpb.2025.10.003_bib11","doi-asserted-by":"crossref","DOI":"10.1093\/bjs\/znae039","article-title":"Standardizing definitions and terminology of left-sided pancreatic resections through an international Delphi consensus","volume":"111","author":"van Ramshorst","year":"2024","journal-title":"Br J Surg"},{"key":"10.1016\/j.hpb.2025.10.003_bib12","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.surg.2007.05.005","article-title":"Delayed Gastric Emptying (DGE) after pancreatic surgery: a suggested definition by the International Study Group of pancreatic surgery (ISGPS)","volume":"142","author":"Wente","year":"2007","journal-title":"Surgery"},{"key":"10.1016\/j.hpb.2025.10.003_bib13","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.surg.2007.02.001","article-title":"Postpancreatectomy Hemorrhage (PPH)-an International Study Group of pancreatic surgery (ISGPS) definition","volume":"142","author":"Wente","year":"2007","journal-title":"Surgery"},{"key":"10.1016\/j.hpb.2025.10.003_bib14","first-page":"584","article-title":"The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 years after","volume":"161","author":"Bassi","year":"2017","journal-title":"Surgery (United States)"},{"key":"10.1016\/j.hpb.2025.10.003_bib15","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1111\/his.14540","article-title":"Dataset for the reporting of carcinoma of the exocrine pancreas: recommendations from the international collaboration on cancer reporting (ICCR)","volume":"79","author":"Verbeke","year":"2021","journal-title":"Histopathology"},{"key":"10.1016\/j.hpb.2025.10.003_bib16","series-title":"R: a language and environment for statistical computing foundation for statistical computing","year":"2020"},{"key":"10.1016\/j.hpb.2025.10.003_bib17","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.hbpd.2022.02.003","article-title":"Risk factors and outcomes for patients with pancreatic cancer undergoing surgical exploration without resection due to metastatic disease: a national cohort Study","volume":"21","author":"Sahlstr\u00f6m","year":"2022","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"10.1016\/j.hpb.2025.10.003_bib18","article-title":"Meta-analysis of FOLFIRINOX-based neoadjuvant therapy for locally advanced pancreatic cancer","volume":"100","author":"Chen","year":"2021","journal-title":"Medicine (United States)"},{"key":"10.1016\/j.hpb.2025.10.003_bib19","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1001\/jamasurg.2019.2277","article-title":"Outcomes of primary chemotherapy for borderline resectable and locally advanced pancreatic ductal adenocarcinoma","volume":"154","author":"Maggino","year":"2019","journal-title":"JAMA Surg"},{"key":"10.1016\/j.hpb.2025.10.003_bib20","doi-asserted-by":"crossref","DOI":"10.1093\/bjsopen\/zrad137","article-title":"Resection rates and intention-to-treat outcomes in borderline and locally advanced pancreatic cancer: real-World data from a Population-Based, prospective cohort Study (NORPACT-2)","volume":"7","author":"Farnes","year":"2023","journal-title":"BJS Open"},{"key":"10.1016\/j.hpb.2025.10.003_bib21","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1093\/jnci\/djac018","article-title":"FOLFIRINOX as initial treatment for localized pancreatic adenocarcinoma: a retrospective analysis by the trans-atlantic pancreatic surgery consortium","volume":"114","author":"Janssen","year":"2022","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.hpb.2025.10.003_bib22","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1002\/jso.26781","article-title":"The aborted whipple: why, and what happens next?","volume":"125","author":"Shah","year":"2022","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.hpb.2025.10.003_bib23","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/j.hpb.2021.09.002","article-title":"Locally advanced pancreatic cancer: a reliable contraindication to resection in the modern era?","volume":"24","author":"Fromer","year":"2022","journal-title":"HPB"},{"key":"10.1016\/j.hpb.2025.10.003_bib24","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s00595-016-1426-1","article-title":"Effect of postoperative major complications on prognosis after pancreatectomy for pancreatic cancer: a retrospective review","volume":"47","author":"Watanabe","year":"2017","journal-title":"Surg Today"},{"key":"10.1016\/j.hpb.2025.10.003_bib25","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.21037\/jgo-2020-slapc-04","article-title":"Resectable, borderline, and locally advanced pancreatic Cancer\u2014\u201cthe good, the bad, and the ugly\u201d candidates for surgery?","volume":"12","author":"Bratlie","year":"2021","journal-title":"J Gastrointest Oncol"},{"key":"10.1016\/j.hpb.2025.10.003_bib26","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s00066-020-01680-2","article-title":"R0 resection following chemo (Radio)Therapy improves survival of primary inoperable pancreatic cancer patients. Interim results of the German randomized CONKO-007\u00b1 trial","volume":"197","author":"Fietkau","year":"2021","journal-title":"Strahlenther Onkol"}],"container-title":["HPB"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1365182X25016454?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1365182X25016454?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T05:44:16Z","timestamp":1775195056000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1365182X25016454"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S1365182X25016454"],"URL":"https:\/\/doi.org\/10.1016\/j.hpb.2025.10.003","relation":{},"ISSN":["1365-182X"],"issn-type":[{"value":"1365-182X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Success rate of salvage neoadjuvant chemotherapy for unexpectedly identified locally advanced pancreatic ductal adenocarcinoma during surgical exploration","name":"articletitle","label":"Article Title"},{"value":"HPB","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hpb.2025.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 International Hepato-Pancreato-Biliary Association Inc. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}